SOLICITATION NOTICE
E -- BSL3 Lab
- Notice Date
- 8/7/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- SS1061915
- Archive Date
- 9/1/2009
- Point of Contact
- Jaclyn Stielper, Phone: 301-827-7153, Doreen Williams , Phone: 301-827-3366
- E-Mail Address
-
jaclyn.stielper@fda.hhs.gov, doreen.williams@fda.hhs.gov
(jaclyn.stielper@fda.hhs.gov, doreen.williams@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- The point of contact for this action is Jaclyn Stielper, Contract Specialist, email Jaclyn.Stielper@FDA.HHS.GOV. The Food and Drug Administration, Rockville, MD intends to negotiate solely with BioQual Inc. as prescribed in FAR 6.302-1. BIOQUAL, INC. 9600 MEDICAL CTR DR STE 200 ROCKVILLE, MD 20850-6329 The contractor shall provide a BSL-3 Lab. The CDC and NIH have classified SARS as a pathogen to be handled only in facilities having in place special conditions, equipment and procedures termed “biosafety level 3” (BSL-3). Furthermore, because the agents are potentially transmissible to farm animals, the USDA requires that laboratories working with the two agents be USDA-inspected and certified. The Bioqual laboratories are one of the few East Coast BSL-3 facilities currently certified by CDC for handling SARS; it is the only such facility in the Washington DC area close enough to the FDA to permit regular interactions with FDA investigators. Furthermore, FDA researchers need to travel from NIH campus to the BSL3 facility more than once a day. SARS is an emerging infectious disease, and the work related to developing a SARS vaccine has been on hold for the past three years while waiting for our BSL-3 laboratory to be constructed. Ironically, the very week that the BSL-3 lab was about to be certified by NIH safety, the H1N1 work was elevated to requiring BSL-3 laboratory containment, and so the lab was certified for the H1N1 work instead. Now the SARS work is on hold again for at least several months or more, while waiting for the H1N1 work to be completed. It is critical to protecting the public health that the SARS work not be delayed any longer. Period Of Performance: Three (3) weeks from Date Of Award. North American Industry Classification System NAICS for this requirement is 541711. Interested persons may identify their interest, in writing, to the Government point of contact. responses to this notice must be received no later than 4:30 PM EST on August 17, 2009. This notice of intent is not a request for competitive proposals or a solicitation of offers.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/SS1061915/listing.html)
- Place of Performance
- Address: Contractor's Facility, United States
- Record
- SN01903822-W 20090809/090808000823-44505f7ee1dd3868e7040256d8978336 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |